George B. Breen, David E. Matyas, and Erica F. Sibley, attorneys in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, co-authored an article in Law360, titled “Health Care Fraud Enforcement in 2018, and 2019 Predictions.”

Following is an excerpt (see below to download the full version in PDF format):

Two years into the Trump administration, the federal and state governments continue to affirm their commitment to ferreting out health care fraud. In fact, in fiscal year 2018, the U.S. Department of Justice obtained $2.88 billion in settlements and judgments from civil fraud and False Claims Act cases. Of this, over $2.5 billion (i.e., almost 90 percent) was generated from health care-related matters with qui tam relators remaining the principal driver of the DOJ’s FCA enforcement efforts. A review of 2018 trends in health care fraud enforcement will serve as a significant predictor of the ongoing and potentially new DOJ policy initiatives for 2019. …

DOJ Continues to Shift Department Policy Due to Granston and Brand Memoranda

Two significant guidance documents were made public in 2018 that suggest how the DOJ has, and will be, reevaluating its policy on two key areas of enforcement actions under the FCA. …

DOJ Remains Focused on Individual Accountability in Corporate Investigations, But Differentiates Between Criminal and Civil Cases

In a November 2018 speech, Deputy Attorney General Rod Rosenstein announced changes to the DOJ’s policy concerning individual accountability in corporate cases, which had most recently been addressed in the September 2015 memorandum issued by then-Deputy Attorney General Sally Yates.[6] While reiterating the DOJ’s commitment to pursuing individual accountability, the newly announced revisions indicate that the DOJ seeks to ease away from some of the strict rules on cooperation credit introduced by the Yates memo, and grants prosecutors some flexibility in resolving civil and criminal enforcement matters. …

Focus on Liability of Institutional Owners and Board Members

Last year also saw cases emerge in which the federal government has taken action against not only members of the senior management team but also members of boards of directors and institutional investors (e.g., private equity firms). In addition to DOJ attorneys, some courts have demonstrated comfort in subjecting private equity stakeholders and boards of directors to potential liability under FCA causes of action. …



Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.